Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease

Abstract Amyloid precursor protein (APP) is a widely expressed transmembrane protein of unknown function that is involved in the pathogenesis of Alzheimer's disease (AD). We investigated the involvement of phospholipase D (PLD) in the pathophysiology of AD. We showed dramatic upregulation of PL...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of aging Vol. 28; no. 7; pp. 1015 - 1027
Main Authors Jin, Jae-Kwang, Ahn, Bong-Hyun, Na, Yeo-Jung, Kim, Jae-Il, Kim, Yong-Sun, Choi, Eun-Kyoung, Ko, Young-Gyu, Chung, Kwang Chul, Kozlowski, Piotr B, Min, Do Sik
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Amyloid precursor protein (APP) is a widely expressed transmembrane protein of unknown function that is involved in the pathogenesis of Alzheimer's disease (AD). We investigated the involvement of phospholipase D (PLD) in the pathophysiology of AD. We showed dramatic upregulation of PLD1 immunoreactivity in reactive astroglial cells in brain tissue sections from authentic AD patients. Expression and activity of PLD1 were up-regulated in brain tissues from AD patients, especially caveolae membrane fraction, compared with those of control brains. Interestingly, PLD1 physically interacts and colocalizes with APP and caveolin-3. We found that APP was associated with the pleckstrin homology domain of PLD1, and the amyloid region of APP interacted with PLD. Elevated expression of APP stimulated PLD activity in human astroglioma cells. These results suggest that up-regulation of PLD might have a role in the neuronal pathology associated with AD.
ISSN:0197-4580
1558-1497
DOI:10.1016/j.neurobiolaging.2006.05.022